RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Chronicity of depression and molecular markers in a large sample of Han Chinese women
Research Article: Molecular Markers and Depression Heterogeneity
Edwards, A. C., Aggen, S. H., Cai, N., Bigdeli, T. B., Peterson, R. E., Docherty, A. R., Webb, B. T., Bacanu, S., Flint, J., & Kendler, K. S. (2016). Chronicity of depression and molecular markers in a large sample of Han Chinese women: Research Article: Molecular Markers and Depression Heterogeneity. Depression and Anxiety, 33(11), 1048-1054. https://doi.org/10.1002/da.22517, https://doi.org/10.1002/da.2016.33.issue-11
BackgroundMajor depressive disorder (MDD) has been associated with changes in mean telomere length and mitochondrial DNA (mtDNA) copy number. This study investigates if clinical features of MDD differentially impact these molecular markers.MethodsData from a large, clinically ascertained sample of Han Chinese women with recurrent MDD were used to examine whether symptom presentation, severity, and comorbidity were related to salivary telomere length and/or mtDNA copy number (maximum N=5,284 for both molecular and phenotypic data).ResultsStructural equation modeling revealed that duration of longest episode was positively associated with mtDNA copy number, while earlier age of onset of most severe episode and a history of dysthymia were associated with shorter telomeres. Other factors, such as symptom presentation, family history of depression, and other comorbid internalizing disorders, were not associated with these molecular markers.ConclusionsChronicity of depressive symptoms is related to more pronounced telomere shortening and increased mtDNA copy number among individuals with a history of recurrent MDD. As these molecular markers have previously been implicated in physiological aging and morbidity, individuals who experience prolonged depressive symptoms are potentially at greater risk of adverse medical outcomes.